The weekly injection for diabetes refers to a class of medications called GLP-1 receptor agonists, which are given as a once-weekly shot under the skin to help control blood sugar in people with type 2 diabetes. There are currently four once-weekly options available in the U.S.: semaglutide (Ozempic), dulaglutide (Trulicity), tirzepatide (Mounjaro), and exenatide extended-release (Bydureon). These medications have become increasingly popular because they lower blood sugar effectively, promote weight loss, and only require one injection per week instead of daily shots.
How Weekly Injections Work
These medications mimic a natural gut hormone called GLP-1 that your body releases after eating. In their modified form, they last much longer in the bloodstream than the natural hormone, which is why one shot per week is enough.
They work through several pathways at once. First, they boost insulin production from the pancreas, but only when blood sugar is actually elevated. This is an important distinction because it means they carry a much lower risk of causing dangerously low blood sugar compared to some older diabetes medications. At the same time, they suppress glucagon, a hormone that tells your liver to release stored sugar into the blood. The net effect is that blood sugar stays more stable throughout the day, especially after meals.
The third mechanism is one that patients tend to notice the most: these drugs slow down how quickly food leaves your stomach. That means sugar and fat from a meal enter your bloodstream more gradually, preventing the sharp spikes that typically follow eating. It also contributes to the feeling of fullness that leads many people to eat less. On top of all this, these medications act on satiety centers in the brain, reducing appetite directly.
The Four Weekly Options
Semaglutide (Ozempic)
Semaglutide is the most widely recognized weekly injection for diabetes. In clinical trials, the 0.5 mg dose reduced A1C by an additional 0.32 to 0.79 percentage points compared to other diabetes drugs, while the 1.0 mg dose reduced it by 0.38 to 1.07 percentage points. Weight loss ranged from about 5 to 15 pounds beyond what comparator medications achieved, depending on the dose and trial. Semaglutide is also available in a daily pill form (Rybelsus), but the weekly injection is the more commonly prescribed version for blood sugar control.
Dulaglutide (Trulicity)
Dulaglutide was one of the first weekly injectables to gain widespread use. It received an additional approval in 2020 to reduce the risk of major cardiovascular events, including heart attack and stroke, in adults with type 2 diabetes who have heart disease or multiple risk factors for it. That makes it a particularly common choice for people whose diabetes management also needs to account for heart health.
Tirzepatide (Mounjaro)
Tirzepatide is the newest of the group and works slightly differently. Rather than targeting only the GLP-1 receptor, it activates two receptors: GLP-1 and GIP (another gut hormone involved in insulin release and appetite). This dual action appears to give it an edge. In the SURPASS clinical trial program, tirzepatide produced greater A1C reductions and more weight loss at all three available doses compared to semaglutide. For people who need aggressive blood sugar and weight management, tirzepatide tends to deliver the strongest results currently available.
Exenatide Extended-Release (Bydureon)
Exenatide extended-release was actually the first GLP-1 medication reformulated for weekly dosing. It remains an option, though it’s prescribed less frequently now that newer alternatives with stronger clinical data are available.
What to Expect With Side Effects
Stomach-related side effects are the most common issue with all weekly injectables. Nausea is the number one complaint across clinical trials for every medication in this class. Vomiting, diarrhea, and constipation also occur, though less frequently. The good news is that for most people, these effects are mild to moderate and fade within the first few weeks as the body adjusts.
Interestingly, the longer-acting weekly formulations tend to cause less nausea and vomiting than daily versions of similar drugs, though they may cause slightly more diarrhea. This is likely because the weekly versions deliver a steadier, more sustained dose rather than a sharp daily spike.
Simple dietary changes can make a real difference in managing these side effects. Eating smaller portions more frequently, choosing bland and low-fat foods, eating slowly, and stopping when you feel full all help. Avoiding spicy or greasy food, not lying down right after eating, and staying hydrated with small sips of clear fluids are also effective strategies. For nausea specifically, crackers, apples, mint, and ginger-based drinks can ease symptoms. Most clinicians will start you on the lowest dose and increase gradually, giving your body time to adapt before ramping up.
How the Injections Are Given
All weekly diabetes injections come in pre-filled pen devices that make self-injection straightforward. You don’t need to measure or draw up medication. The needles are short and thin, designed for injection just beneath the skin rather than into muscle.
The four recommended injection areas are the stomach (abdomen), outer thighs, backs of the upper arms, and upper outer hips. Rotating between these sites is important because using the same spot repeatedly can cause scar tissue to build up, which looks like swelling or a hard lump and makes the medication harder to absorb properly. A good rule of thumb is to pick the same general area each week (for consistency in absorption) but shift the exact spot by at least an inch or two.
You can give the injection on any day of the week, but it helps to pick the same day each time. If you forget, most of these medications can be taken within a few days of the missed dose, though the specific rules vary by product.
Storing Your Pen
Before first use, pens need to be stored in the refrigerator between 36°F and 46°F (2°C to 8°C). Keep them away from the back wall and freezer vents where they might accidentally freeze, because a frozen pen must be thrown away.
Once you’ve used a pen for the first time, it can be kept at room temperature, below 86°F (30°C), out of direct sunlight. Store it with the needle removed. Each product has a specific number of days it stays good at room temperature after opening, which is printed on the packaging, so check that when you start a new pen.
How Doctors Decide Which One to Prescribe
The choice between weekly injectables depends on several factors. If cardiovascular protection is a priority, dulaglutide and semaglutide both have strong evidence for reducing heart-related events. If maximum blood sugar reduction and weight loss are the primary goals, tirzepatide currently has the best clinical data. Insurance coverage and cost often play the biggest role in practice, since these medications can be expensive without coverage, and formularies vary widely between plans.
Most people start at the lowest available dose and increase every four weeks or so, depending on how well they tolerate the medication and how much their blood sugar improves. This gradual approach minimizes side effects and lets the prescriber find the lowest effective dose. The full benefit of these medications typically becomes clear after several months of use at the target dose.